Could a simple machine take the sting out of breast cancer injections?

NCT ID NCT07533526

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two ways of giving a large-volume subcutaneous injection of targeted therapy (pertuzumab and trastuzumab) to 40 women with HER2-positive breast cancer. Each patient will receive one injection by a nurse using a stopwatch to mimic a steady speed, and another injection by a medical pump that delivers the drug at a constant rate. The goal is to see which method causes less pain, with the hope that machine-driven injections could improve the treatment experience.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
pertuzumab and trastuzumab (Phesgo) given via subcutaneous injection
What this could lead to
If successful, this could show that using a machine for slow, steady injections reduces pain and improves comfort for breast cancer patients.
What could go wrong
This is a small, early-stage study with only 40 patients, so results may not apply to everyone. The manual injection is timed to match the machine, so any difference in pain might be small.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medical Ethics Committee of Sun Yat-sen Memorial Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, 510000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.